Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #133
1223
mi
from
Philadelphia, PA
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #133
1223
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #198
520
mi
from
Jackson, TN
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #198
520
mi
from
Jackson, TN
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #379
777
mi
from
Salt Lake City, UT
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #379
777
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Research Site #131
1182
mi
from
Norfolk, VA
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Research Site #131
1182
mi
from
Norfolk, VA
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #196
1398
mi
from
Puyallup, WA
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #196
1398
mi
from
Puyallup, WA
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #612
1214
mi
from
Calgary,
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #612
1214
mi
from
Calgary,
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #387
340
mi
from
Dallas, TX
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #387
340
mi
from
Dallas, TX
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #390
1329
mi
from
Stanford, CA
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #390
1329
mi
from
Stanford, CA
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #389
801
mi
from
Atlanta, GA
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #389
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Site #396
697
mi
from
New Orleans, LA
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Site #396
697
mi
from
New Orleans, LA
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #397
1225
mi
from
New York, NY
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #397
1225
mi
from
New York, NY
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #392
728
mi
from
Cincinnati, OH
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #392
728
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Site #393
599
mi
from
Germantown, TN
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Site #393
599
mi
from
Germantown, TN
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #386
1119
mi
from
Falls Church, VA
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #386
1119
mi
from
Falls Church, VA
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #200
1103
mi
from
Manassas, VA
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #200
1103
mi
from
Manassas, VA
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #398
1148
mi
from
Baltimore, MD
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #398
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #202
1253
mi
from
Hillsborough, NJ
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #202
1253
mi
from
Hillsborough, NJ
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #123
158
mi
from
Oklahoma City, OK
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #123
158
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #174
553
mi
from
Saint Paul, MN
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #174
553
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #108
418
mi
from
Saint Louis, MO
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #108
418
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Site #391
1053
mi
from
Charlottesville, VA
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Site #391
1053
mi
from
Charlottesville, VA
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
University of California Los Angeles Medical Center
1178
mi
from
Los Angeles, CA
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
University of California Los Angeles Medical Center
1178
mi
from
Los Angeles, CA
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
JFK Medical Center
1289
mi
from
Atlantis, FL
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
JFK Medical Center
1289
mi
from
Atlantis, FL
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
Delray Medical Center
1294
mi
from
Delray Beach, FL
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
Delray Medical Center
1294
mi
from
Delray Beach, FL
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
Palmetto General Hospital
1313
mi
from
Hialeah, FL
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
Palmetto General Hospital
1313
mi
from
Hialeah, FL
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
Florida Hospital Orlando
1141
mi
from
Orlando, FL
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
Florida Hospital Orlando
1141
mi
from
Orlando, FL
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
Palm Beach Gardens Medical Center
1276
mi
from
Palm Beach Gardens, FL
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
Palm Beach Gardens Medical Center
1276
mi
from
Palm Beach Gardens, FL
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
Memorial Hospital West
1304
mi
from
Pembroke Pines, FL
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
Memorial Hospital West
1304
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
Emory Midtwon
803
mi
from
Atlanta, GA
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
Emory Midtwon
803
mi
from
Atlanta, GA
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
Emory University
801
mi
from
Atlanta, GA
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
Emory University
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
Alexian Brothers Heart and Vascular Institute
598
mi
from
Elk Grove Village, IL
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
Alexian Brothers Heart and Vascular Institute
598
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
St. John's Springfield
462
mi
from
Springfield, IL
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
St. John's Springfield
462
mi
from
Springfield, IL
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
Community Heart and Vascular
643
mi
from
Indianapolis, IN
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
Community Heart and Vascular
643
mi
from
Indianapolis, IN
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
Methodist
614
mi
from
Merrillville, IN
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
Methodist
614
mi
from
Merrillville, IN
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
Central Baptist Hospital
724
mi
from
Lexington, KY
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
Central Baptist Hospital
724
mi
from
Lexington, KY
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
McLaren Bay Region
832
mi
from
Bay City, MI
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
McLaren Bay Region
832
mi
from
Bay City, MI
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
St. John's
837
mi
from
Detroit, MI
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
St. John's
837
mi
from
Detroit, MI
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
Crittenton Hospital
844
mi
from
Rochester, MI
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
Crittenton Hospital
844
mi
from
Rochester, MI
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
University of Minnesota Medical Center
552
mi
from
Minneapolis, MN
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
University of Minnesota Medical Center
552
mi
from
Minneapolis, MN
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
Columbia University
1290
mi
from
New York, NY
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
Columbia University
1290
mi
from
New York, NY
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
LIJ Health System
1225
mi
from
New York, NY
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
LIJ Health System
1225
mi
from
New York, NY
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
Metrohealth
893
mi
from
Cleveland, OH
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
Metrohealth
893
mi
from
Cleveland, OH
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
Hillcrest Oklahoma Heart Institute
149
mi
from
Tulsa, OK
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
Hillcrest Oklahoma Heart Institute
149
mi
from
Tulsa, OK
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
University of Texas Medical Branch
607
mi
from
Galveston, TX
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
University of Texas Medical Branch
607
mi
from
Galveston, TX
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
St. Luke's Episcopal Hospital
572
mi
from
Houston, TX
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
St. Luke's Episcopal Hospital
572
mi
from
Houston, TX
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
Heart Hospital Plano
332
mi
from
Plano, TX
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
Heart Hospital Plano
332
mi
from
Plano, TX
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
Davis Hospital and Medical Center
788
mi
from
Layton, UT
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
Davis Hospital and Medical Center
788
mi
from
Layton, UT
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
Charleston Area Medical Center
883
mi
from
Charleston, WV
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
Charleston Area Medical Center
883
mi
from
Charleston, WV
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
San Biovanni Hospital
5402
mi
from
Rome,
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
San Biovanni Hospital
5402
mi
from
Rome,
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
McLaren Macomb
855
mi
from
Mount Clemens, MI
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
McLaren Macomb
855
mi
from
Mount Clemens, MI
Click here to add this to my saved trials